A Comparison of Buccal Midazolam and Intravenous Diazepam for the Acute Treatment of Seizures in Children

AUTHORS

Ali Mazrooei 1 , Seyed-Hassan Tonekaboni 2 , Mohammad Ghofrani 3 , Farhad Mahvelati Shamsabadi 3 , *

1 1. Department of Pediatrics, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Department of Pediatrics, Shahid Beheshti University of Medical Sciences, Tehran & Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 1. Department of Pediatrics, Shahid Beheshti University of Medical Sciences, Tehran & Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

How to Cite: Mazrooei A, Tonekaboni S, Ghofrani M, Mahvelati Shamsabadi F. A Comparison of Buccal Midazolam and Intravenous Diazepam for the Acute Treatment of Seizures in Children, Iran J Pediatr. 2015 ; 22(3):303-308.

ARTICLE INFORMATION

Iranian Journal of Pediatrics: 22 (3); 303-308
Published Online: September 30, 2012
Article Type: Research Article
Received: May 29, 2011
Accepted: March 03, 2012

Crossmark

CHEKING

READ FULL TEXT
Abstract

Objective: The purpose of the present study is to compare efficacy and safety of buccal midazolam with intravenous diazepam in control of seizures in Iranian children.
Methods: This is a randomized clinical trial. 92 patients with acute seizures, ranging from 6 months to 14 years were randomly assigned to receive either buccal midazolam (32 cases) or intravenous diazepam (60 cases) at the emergency department of a children's hospital. The primary outcome of this study was cessation of visible seizure activity within 5 minutes from administration of the first dosage. The second dosage was used in case the seizure remained uncontrolled 5 minutes after the first one.
Findings: In the midazolam group, 22 (68.8%) patients were relieved from seizures in 10 minutes. Meanwhile, diazepam controlled the episodes of 42 (70%) patients within 10 minutes. The difference was, however, not statistically significant (P=0.9). The mean time required to control the convulsive episodes after administration of medications was not statistically significant (P=0.09). No significant side effects were observed in either group. Nevertheless, the risk of respiratory failure in intravenous diazepam is greater than in buccal midazolam.
Conclusion: Buccal midazolam is as effective as and safer than intravenous diazepam in control of seizures.

 

Keywords

Midazolam Diazepam Myoclonic Seizure Disorder Buccal Drug Administration Intravenous Injections Childhood

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1.

    References are available in PDF.

  • COMMENTS

    LEAVE A COMMENT HERE: